Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test
Status unconfirmed · Not applicable
Conditions studied: Kidney Transplant Rejection, Immunosuppression
In brief
This is an investigator-initiated, single-center, prospective, randomized, proof of concept study. In this study patients who are status post kidney transplantation and meet the inclusion and exclusion criteria will undergo immunosuppression reduction and will be followed closely to assess stability of graft function.
Key facts
- Study ID
- NCT04670926
- Run by
- Transplant Genomics, Inc.
- People needed
- 75
- Starts
- 2021-06-03
- Expected to finish
- 2023-09-30
- Last updated by the study team
- 2021-08-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- California Pacific Medical Center — San Francisco, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.